Clincosm LogoSign in Get a demo

Colon Cancer

Showing NaN - NaN of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Colon Cancer Trial in Houston (Cemiplimab)

Not yet recruiting
  • Colon Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2023

Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 31, 2023

Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)

Not yet recruiting
  • Colon Cancer
  • Colorectal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Risk Communication Within Mexican-American Families

Completed
  • Breast Cancer
  • +3 more
  • Family Health History
  • Houston, Texas
    MD Anderson Cancer Center
Jan 13, 2023

Gynecologic Cancer, Ovary Cancer, Pancreatic Cancer Trial in Houston (Free genetic testing and counseling group, IGNITE-TX

Not yet recruiting
  • Gynecologic Cancer
  • +8 more
  • Free genetic testing and counseling group
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Jan 11, 2023

Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
Dec 22, 2022

NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Scottsdale, Arizona
  • +84 more
Oct 10, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of

Recruiting
  • Advanced Cancer
  • +6 more
  • Dose escalation: COM902 monotherapy.
  • +3 more
  • Grand Rapids, Michigan
  • +5 more
Aug 8, 2022

Colon Cancer, Resected Stage Trial in Houston (Cetuximab, CB-NK-TGF-βR2-/NR3C1, Fludarabine phosphate)

Recruiting
  • Colon Cancer
  • Resected Stage
  • Houston, Texas
    M D Anderson Cancer Center
Jul 23, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Malignant Tumors of Digestive Organs, Colorectal Cancer, Colon Cancer Trial in Houston (Durvalumab, Trametinib)

Completed
  • Malignant Neoplasms of Digestive Organs
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 23, 2022

Prevention of Colorectal Cancer Through Multiomics Blood Testing

Recruiting
  • Colon Cancer
  • +10 more
  • Freenome test
  • Anniston, Alabama
  • +173 more
Mar 9, 2022

Colorectal Cancer, Colon Cancer Trial in Houston (drug, dietary supplement, other, behavioral)

Recruiting
  • Colorectal Cancer
  • Colon Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 3, 2021

Lung Cancer, Breast Cancer, Colon Cancer Trial in Houston, White River Junction (SAFER TRACKS Intervention)

Active, not recruiting
  • Lung Cancer
  • +4 more
  • SAFER TRACKS Intervention
  • Houston, Texas
  • +1 more
Nov 2, 2021

Solid Tumor, Breast Cancer, Colon Cancer Trial in Worldwide (LY3039478, Taladegib, Abemaciclib)

Completed
  • Solid Tumor
  • +4 more
  • Miami, Florida
  • +10 more
Aug 13, 2020

Cancer, Malignancy, Neoplasia Trial in United States (ASN007: ascending doses, ASN007 RD)

Completed
  • Cancer
  • +18 more
  • ASN007: ascending doses
  • ASN007 RD
  • Tampa, Florida
  • +4 more
Jul 7, 2020

Early Detection of Colorectal Adenocarcinoma

Completed
  • Colon Cancer
  • Rectal Cancer
    • Boston, Massachusetts
    • +8 more
    Jan 14, 2020

    Colon Cancer Trial in Hartford, Chapel Hill, Houston (Survivorship CHESS, Control)

    Completed
    • Colon Cancer
    • Survivorship CHESS
    • Control
    • Hartford, Connecticut
    • +2 more
    Nov 14, 2019

    Prognostic Molecular and Environmental Factors in High-Risk

    Unknown status
    • Colon Cancer
    • Questionnaire
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    May 8, 2019

    Assessment of Recurrence Risk in Stage II Colon Cancer Patients

    Unknown status
    • Colon Cancer
      • Glendale, California
      • +34 more
      Jan 8, 2019

      Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer Trial in Worldwide (denosumab)

      Completed
      Has Results
      • Breast Cancer
      • +15 more
      • Encinitas, California
      • +23 more
      Sep 20, 2018

      Colon Cancer Trial in Houston (antineoplaston A10, antineoplaston AS2-1 (ANP))

      Terminated
      • Colon Cancer
      • antineoplaston A10, antineoplaston AS2-1 (ANP)
      • Houston, Texas
        Burzynski Clinic
      Sep 26, 2017

      Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer

      Completed
      • Colon Cancer
      • Questionnaire
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Mar 10, 2016